Argan (NYSE:AGX – Get Free Report) is expected to post its Q2 2027 results after the market closes on Wednesday, September 2nd. Analysts expect Argan to post earnings of $2.64 per share and revenue of $300.5260 million for the quarter. Individuals may review the information on the company’s upcoming Q2 2027 earning overview page for the latest details on the call scheduled for Wednesday, September 2, 2026 at 5:00 PM ET.
Argan (NYSE:AGX – Get Free Report) last released its earnings results on Thursday, June 4th. The construction company reported $3.24 EPS for the quarter, beating the consensus estimate of $2.31 by $0.93. The firm had revenue of $290.95 million for the quarter, compared to analyst estimates of $256.03 million. Argan had a net margin of 15.48% and a return on equity of 36.89%. The business’s quarterly revenue was up 50.2% compared to the same quarter last year. During the same period last year, the firm earned $1.60 EPS. On average, analysts expect Argan to post $13 EPS for the current fiscal year and $17 EPS for the next fiscal year.
Argan Trading Up 0.5%
Shares of NYSE:AGX opened at $419.92 on Monday. The firm has a 50 day moving average of $606.83 and a 200-day moving average of $584.42. Argan has a 12 month low of $197.00 and a 12 month high of $805.75. The stock has a market capitalization of $5.89 billion, a PE ratio of 36.90 and a beta of 0.61.
Argan Announces Dividend
Insider Buying and Selling
In related news, Director John Ronald Jr. Jeffrey sold 5,716 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $579.64, for a total transaction of $3,313,222.24. Following the completion of the transaction, the director directly owned 2,533 shares in the company, valued at $1,468,228.12. This represents a 69.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Karen Sweeney sold 300 shares of the stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $705.00, for a total transaction of $211,500.00. Following the completion of the transaction, the director directly owned 1,548 shares of the company’s stock, valued at approximately $1,091,340. The trade was a 16.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 127,973 shares of company stock worth $87,554,828 in the last quarter. Corporate insiders own 2.99% of the company’s stock.
Institutional Trading of Argan
A number of hedge funds and other institutional investors have recently modified their holdings of AGX. Millennium Management LLC lifted its stake in shares of Argan by 12.2% in the 1st quarter. Millennium Management LLC now owns 117,805 shares of the construction company’s stock valued at $15,452,000 after acquiring an additional 12,854 shares during the last quarter. NewEdge Advisors LLC grew its position in Argan by 118.3% during the 1st quarter. NewEdge Advisors LLC now owns 5,316 shares of the construction company’s stock worth $697,000 after acquiring an additional 2,881 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Argan by 13.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 35,567 shares of the construction company’s stock worth $4,665,000 after purchasing an additional 4,196 shares in the last quarter. Intech Investment Management LLC increased its holdings in Argan by 37.3% in the 1st quarter. Intech Investment Management LLC now owns 8,985 shares of the construction company’s stock worth $1,179,000 after purchasing an additional 2,442 shares in the last quarter. Finally, Hsbc Holdings PLC bought a new position in Argan in the second quarter valued at about $286,000. Institutional investors own 79.43% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the company. Weiss Ratings upgraded Argan from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday. Lake Street Capital lifted their price target on Argan from $375.00 to $600.00 and gave the company a “hold” rating in a research note on Friday, June 5th. Wall Street Zen lowered Argan from a “buy” rating to a “hold” rating in a research note on Saturday, August 22nd. Finally, Zacks Research cut Argan from a “strong-buy” rating to a “hold” rating in a report on Friday, August 7th. Four investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Argan has an average rating of “Moderate Buy” and a consensus target price of $470.40.
View Our Latest Stock Analysis on AGX
About Argan
Argan, Inc (NYSE: AGX) is a holding company that provides professional technical and management services to the power generation and renewable energy industries. Through its wholly owned subsidiaries, the company delivers engineering, procurement and construction management (EPCM), commissioning and operations and maintenance (O&M) services for a broad range of energy facilities. Argan focuses on projects for utility, industrial and municipally owned clients, helping to bring efficient thermal and renewable energy plants into operation and maintain optimal performance over the asset life cycle.
The company’s principal subsidiaries include Gemma Power Systems, which specializes in turnkey construction of combined-cycle, simple-cycle, cogeneration and renewable energy plants; Atlantic Projects Company, which provides electrical balance-of-plant, control systems, instrumentation and commissioning services; and Infrastructure Solutions, which offers industrial maintenance, outage support and modification services.
Read More
- Five stocks we like better than Argan
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Argan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argan and related companies with MarketBeat.com's FREE daily email newsletter.
